| 000 | 01524 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513040909.0 | ||
| 264 | 0 | _c19950505 | |
| 008 | 199505s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/0169-5002(94)92167-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFuruse, K | |
| 245 | 0 | 0 |
_aA phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cDec 1994 |
||
| 300 |
_a385-91 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aVinblastine _xadverse effects |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aKubota, K | |
| 700 | 1 | _aKawahara, M | |
| 700 | 1 | _aOgawara, M | |
| 700 | 1 | _aKinuwaki, E | |
| 700 | 1 | _aMotomiya, M | |
| 700 | 1 | _aNishiwaki, Y | |
| 700 | 1 | _aNiitani, H | |
| 700 | 1 | _aSakuma, A | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 11 _gno. 5-6 _gp. 385-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0169-5002(94)92167-9 _zAvailable from publisher's website |
| 999 |
_c7703897 _d7703897 |
||